Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A P Passmore

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Neuromolecular Medicine|June 27, 2008
BACE1 polymorphisms do not influence platelet membrane beta-secretase activity or genetic susceptibility for Alzheimer's disease in the Northern Irish populationS Todd, A J McKnight, W W Liu, et al.
Lancet (London, England)|March 29, 2001
Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control studyS M McCusker, M D Curran, K B Dynan, et al.
Neurobiology of Aging|December 19, 2006
Platelet beta-secretase activity is increased in Alzheimer's diseaseJ A Johnston, W W Liu, D T R Coulson, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Pharmacokinetics of flosequinan in patients with heart failureD P Nicholls, A Droogan, C A Carson, et al.
International Journal of Clinical Practice|August 9, 2002
A multinational, randomised, 12-week, comparative study of donepezil and rivastigmine in patients with mild to moderate Alzheimer's diseaseD G Wilkinson, A P Passmore, R Bullock, et al.
Clinical Chemistry and Laboratory Medicine|November 9, 2000
Apolipoprotein E polymorphism and serum concentration in Alzheimer's disease in nine European centres: the ApoEurope study. ApoEurope groupG Siest, P Bertrand, B Qin, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Neuromolecular Medicine|June 27, 2008
BACE1 polymorphisms do not influence platelet membrane beta-secretase activity or genetic susceptibility for Alzheimer's disease in the Northern Irish populationS Todd, A J McKnight, W W Liu, et al.
Lancet (London, England)|March 29, 2001
Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control studyS M McCusker, M D Curran, K B Dynan, et al.
Neurobiology of Aging|December 19, 2006
Platelet beta-secretase activity is increased in Alzheimer's diseaseJ A Johnston, W W Liu, D T R Coulson, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Pharmacokinetics of flosequinan in patients with heart failureD P Nicholls, A Droogan, C A Carson, et al.
International Journal of Clinical Practice|August 9, 2002
A multinational, randomised, 12-week, comparative study of donepezil and rivastigmine in patients with mild to moderate Alzheimer's diseaseD G Wilkinson, A P Passmore, R Bullock, et al.
Clinical Chemistry and Laboratory Medicine|November 9, 2000
Apolipoprotein E polymorphism and serum concentration in Alzheimer's disease in nine European centres: the ApoEurope study. ApoEurope groupG Siest, P Bertrand, B Qin, et al.
Pageof 6